89981-75-9

Usage

Uses

Used in Pharmaceutical Synthesis:
1-(2,4-DICHLORO-PHENYL)-ETHYLAMINE is used as a key intermediate in the synthesis of various pharmaceutical drugs. Its unique chemical structure allows it to be easily modified and incorporated into a wide range of drug molecules, making it a valuable component in the development of new medications.
Used in Medicinal Applications:
1-(2,4-DICHLORO-PHENYL)-ETHYLAMINE is used as a potential therapeutic agent for the treatment of various neurological and psychiatric disorders. Its ability to interact with specific receptors and pathways in the central nervous system makes it a promising candidate for the development of drugs targeting conditions such as depression, anxiety, and other mood disorders.
Used in Medicinal Chemistry and Drug Discovery:
Due to its chemical properties and structure, 1-(2,4-DICHLORO-PHENYL)-ETHYLAMINE has attracted attention in the fields of medicinal chemistry and drug discovery. Researchers are exploring its potential therapeutic benefits and investigating its interactions with biological targets to develop new drugs with improved efficacy and safety profiles.

InChI:InChI=1/C8H9Cl2N/c1-5(11)7-3-2-6(9)4-8(7)10/h2-5H,11H2,1H3/p+1/t5-/m0/s1

Upstream product

• 35588-60-4 p-chloro-(R,S)-1-phenylethylamine 

Downstream Products

• 193014-31-2 ethyl 3-[sec-(2,4-dichlorophenetyl)amino]-4-nitrobenzoate 
• 133492-69-0 2,6-dichlorophenylethylamine 
• 133773-29-2 (R)-2,4-dichloro-α-methylbenzylamine 
• 1528751-77-0 C₁₃H₁₇Cl₂NO 
• 1441785-69-8 2-((R)-1-(2,4-dichlorophenyl)ethylamino)-4-(4-((R)-piperidine-2-carbonyl)piperazin-1-yl)benzonitrile 
• 1441793-56-1 (R)-t-butyl 2-(4-(4-cyano-3-((R)-1-(2,4-dichlorophenyl)ethylamino)phenyl)piperazine-1-carbonyl)piperidine-1-carboxylate 
• 1441793-51-6 (R)-2-(1-(2,4-dichlorophenyl)ethylamino)-4-(piperazin-1-yl)benzonitrile 
• 1441793-45-8 (R)-t-butyl 4-(4-cyano-3-(1-(2,4-dichlorophenyl)ethylamino)phenyl)piperazine-1-carboxylate 
• 1441793-39-0 (R)-4-bromo-2-(1-(2,4-dichlorophenyl)ethylamino)benzonitrile 
• 1441785-53-0 (4-(3-((R)-1-(2,4-dichlorophenyl)ethylamino)-4-fluorophenyl)piperazin-1-yl)((R)-piperidin-2-yl)methanone 
• 1441793-27-6 (R)-t-butyl 2-(4-(3-((R)-1-(2,4-dichlorophenyl)ethylamino)-4-fluorophenyl)piperazine-1-carbonyl)piperidine-1-carboxylate 
• 1441793-21-0 (R)-N-(1-(2,4-dichlorophenyl)ethyl)-2-fluoro-5-(piperazin-1-yl)aniline 
• 1441793-16-3 (R)-t-butyl 4-(3-(1-(2,4-dichlorophenyl)ethylamino)-4-fluorophenyl)piperazine-1-carboxylate 

Relevant academic research and scientific papers

Process for producing optically active 3,3,3-Trifluoro-2-Hydroxy-2-Methylpropionic acid, and salt thereof

There are disclosed are a diastereomer salt of formula (1): a process for producing the same, a process for producing optically active 3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid of formula (2′): a novel optically active amine compound of formula (4): a novel optically active amine compound of formula (8): an imine compound of formula (7) or (11):

N-(α-alkylbenzylidene)-α-phenylalkylamine, its use and process for producing the same and process for producing intermediate therefor

There is disclosed an N-(α-alkylbenzylidene)-α-phenylalkylamine represented by the general formula (1): STR1 wherein R1 represents a lower alkyl group, R2 represents a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxy group and X represents a halogen atom or a lower alkoxy group, its use and a process for producing the same and processes for producing intermediates therefor.

Process for racemization of optically active 1-phenylethylamine derivative

A process for racemization of an optically active 1-phenylethylamine derivative represented by formula (I): STR1 wherein R1 represents a phenyl group substituted at least at the ortho-position, which comprises reacting the optically active 1-phenylethylamine derivative (1) with an aldehyde compound represented by formula (2): where R2 represents an optionally substituted alkyl group or an optionally substituted phenyl group to form an optically active imine represented by formula (3): STR2 reacting the imine with an alkaline metal tert-alkoxide in an aprotic solvent, and then hydrolyzing the resultant racemic imine.